In summary, we have demonstrated that TGF-β1-induced drug resistance in pancreatic cancer was mediated by upregulation of both PKCα and P-gp expression and by induction of the epithelial-to-mesenchymal transition. Here, PRKCA is linked to pancreatic neoplasm.